Progesterone: Difference between revisions
>Lilylunatic Fixed the last interwiki link |
>Lilylunatic Removed breast growth - no actual evidence for that |
||
(18 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{headerpanel| | {{headerpanel|{{DepressantOD|GABAergics|Opioids}}}} | ||
{{SubstanceBox/Progesterone}} | {{SubstanceBox/Progesterone}} | ||
{{SummarySheet}} | {{SummarySheet}} | ||
Line 7: | Line 7: | ||
Progesterone is commonly used as a part of [[wikipedia:Transgender_hormone_therapy|trans-feminising hormone therapy]] or [[wikipedia:Menopause|post menopausal]] [[wikipedia:Hormone replacement therapy|Hormone replacement therapy]]. | Progesterone is commonly used as a part of [[wikipedia:Transgender_hormone_therapy|trans-feminising hormone therapy]] or [[wikipedia:Menopause|post menopausal]] [[wikipedia:Hormone replacement therapy|Hormone replacement therapy]]. | ||
[[File:Progesterone Blister.jpg|thumb|Progesterone | [[File:Progesterone Blister.jpg|thumb|Progesterone Besins 200mg]] | ||
==History and culture== | ==History and culture== | ||
Progesterone was first discovered in 1929 by George W. Corner and Willard M. Allen. By 1934 pure crystalline material was achieved by Adolf Butenandt at the ''[[wikipedia:Gdańsk_University_of_Technology|Chemisches Institut of Technical University]]'' in [[wikipedia:Gdańsk]]. Synthesis was accomplished later that year. | |||
Progesterone was first discovered in 1929 by George W. Corner and Willard M. Allen. By 1934 pure crystalline material was achieved by Adolf Butenandt at the ''[[wikipedia | <ref name="Josimovich 2013 p.">{{cite book | last=Josimovich | first=J.B. | title=Gynecologic Endocrinology | publisher=Springer Science & Business Media |url=https://books.google.com/books?id=9vv2BwAAQBAJ&pg=PA25 |date=11 November 2013 |access-date=1 February 2016 |archive-date=14 January 2023 |archive-url=https://web.archive.org/web/20230114024947/https://books.google.com/books?id=9vv2BwAAQBAJ&pg=PA25| isbn=978-1-4613-2157-6 |pages=9, 25–29 }}</ref> | ||
<ref name="Josimovich 2013 p. ">{{cite book | last=Josimovich | first=J.B. | title=Gynecologic Endocrinology | publisher=Springer Science & Business Media |url=https://books.google.com/books?id=9vv2BwAAQBAJ&pg=PA25 |date=11 November 2013 |access-date=1 February 2016 |archive-date=14 January 2023 |archive-url=https://web.archive.org/web/20230114024947/https://books.google.com/books?id=9vv2BwAAQBAJ&pg=PA25| isbn=978-1-4613-2157-6 |pages=9, 25–29 }}</ref> | |||
In a 2012 study higher levels of progesterone were linked to lower affinity to competitive behavior in women.<ref name="Buser 2012 pp. 1–10">{{cite journal | last=Buser | first=Thomas | title=The impact of the menstrual cycle and hormonal contraceptives on competitiveness|journal=Journal of Economic Behavior & Organization|series=Gender Differences in Risk Aversion and Competition|volume=83|issue=1|pages=1–10|doi=10.1016/j.jebo.2011.06.006|issn=0167-2681|url=https://pure.uva.nl/ws/files/1864146/117489_376503.pdf|access-date=2 February 2024|archive-date=2 February 2024|archive-url=https://web.archive.org/web/20240202143019/https://pure.uva.nl/ws/files/1864146/117489_376503.pdf}}</ref><ref name="Piosik 2003 pp. 135–138">{{cite journal | last=Piosik | first=Romuald | title=Adolf Butenandt und sein Wirken an der Technischen Hochschule Danzig | journal=CHEMKON | volume=10 | issue=3 | date=2003 | issn=0944-5846 | doi=10.1002/ckon.200390038 | pages=135–138}}</ref> | In a 2012 study higher levels of progesterone were linked to lower affinity to competitive behavior in women.<ref name="Buser 2012 pp. 1–10">{{cite journal | last=Buser | first=Thomas | title=The impact of the menstrual cycle and hormonal contraceptives on competitiveness|journal=Journal of Economic Behavior & Organization|series=Gender Differences in Risk Aversion and Competition|volume=83|issue=1|pages=1–10|doi=10.1016/j.jebo.2011.06.006|issn=0167-2681|url=https://pure.uva.nl/ws/files/1864146/117489_376503.pdf|access-date=2 February 2024|archive-date=2 February 2024|archive-url=https://web.archive.org/web/20240202143019/https://pure.uva.nl/ws/files/1864146/117489_376503.pdf}}</ref><ref name="Piosik 2003 pp. 135–138">{{cite journal | last=Piosik | first=Romuald | title=Adolf Butenandt und sein Wirken an der Technischen Hochschule Danzig | journal=CHEMKON | volume=10 | issue=3 | date=2003 | issn=0944-5846 | doi=10.1002/ckon.200390038 | pages=135–138}}</ref> | ||
==Chemistry== | ==Chemistry== | ||
Progesterone is a naturally occurring pregnane steroid and is also known as pregn-4-ene-3,20-dione. It has a double bond (4-ene) between the C4 and C5 positions and two ketone groups (3,20-dione), one at the C3 position and the other at the C20 position.<ref name="Pubchem">{{Cite web|date= 12 March 2024|title= Compound Summary Progesterone| publisher=National Library of Medicine|access-date=12 March 2024|url=https://pubchem.ncbi.nlm.nih.gov/compound/progesterone}}</ref> | Progesterone is a naturally occurring pregnane steroid and is also known as pregn-4-ene-3,20-dione. It has a double bond (4-ene) between the C4 and C5 positions and two ketone groups (3,20-dione), one at the C3 position and the other at the C20 position.<ref name="Pubchem">{{Cite web|date= 12 March 2024|title= Compound Summary Progesterone| publisher=National Library of Medicine|access-date=12 March 2024|url=https://pubchem.ncbi.nlm.nih.gov/compound/progesterone}}</ref> | ||
==Pharmacology== | ==Pharmacology== | ||
Progesterone on it's own acts as a [[antagonist]] on the [[wikipedia:Sigma-2 receptor|'''σ<sub>2</sub>''' receptor]] and as a [[wikipedia:negative allosteric modulator|negative allosteric modulator]] on [[wikipedia:nicotinic acetylcholine receptors|nicotinic acetylcholine receptors]]. However most of the psychoactive effects of progesterone are induced by it's metabolites.<ref name="Gonzalez 2020 p. 1846">{{cite journal | last=Gonzalez | first=Susana Laura | title=Progesterone for the treatment of central nervous system disorders: the many signaling roads for a single molecule | journal=Neural Regeneration Research | volume=15 | issue=10 | date=2020 | issn=1673-5374 | pmid=32246629 | pmc=7513974 | doi=10.4103/1673-5374.280314 | doi-access=free | page=1846}}</ref> | Progesterone on it's own acts as a [[antagonist]] on the [[wikipedia:Sigma-2 receptor|'''σ<sub>2</sub>''' receptor]] and as a [[wikipedia:negative allosteric modulator|negative allosteric modulator]] on [[wikipedia:nicotinic acetylcholine receptors|nicotinic acetylcholine receptors]]. However most of the psychoactive effects of progesterone are induced by it's metabolites.<ref name="Gonzalez 2020 p. 1846">{{cite journal | last=Gonzalez | first=Susana Laura | title=Progesterone for the treatment of central nervous system disorders: the many signaling roads for a single molecule | journal=Neural Regeneration Research | volume=15 | issue=10 | date=2020 | issn=1673-5374 | pmid=32246629 | pmc=7513974 | doi=10.4103/1673-5374.280314 | doi-access=free | page=1846}}</ref> | ||
===Metabolism=== | ===Metabolism=== | ||
Progesterone is mainly metabolised in the liver, therefore the route of administration significantly influences the intensity of experienced effects. The most important metabolites are [[wikipedia:allopregnanolone|allopregnanolone]], [[wikipedia:pregnanolone|pregnanolone]], [[wikipedia:isopregnanolone|isopregnanolone]] and [[wikipedia:epipregnanolone|epipregnanolone]].<ref name="Kolatorova Vitku Suchopar Hill 2022 p. 7989">{{cite journal | last=Kolatorova | first=Lucie | last2=Vitku | first2=Jana | last3=Suchopar | first3=Josef | last4=Hill | first4=Martin | last5=Parizek | first5=Antonin | title=Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine | journal=International Journal of Molecular Sciences | volume=23 | issue=14 | date=2022-07-20 | issn=1422-0067 | pmid=35887338 | doi=10.3390/ijms23147989 | doi-access=free | page=7989}}</ref> | Progesterone is mainly metabolised in the liver, therefore the route of administration significantly influences the intensity of experienced effects. The most important metabolites are [[wikipedia:allopregnanolone|allopregnanolone]], [[wikipedia:pregnanolone|pregnanolone]], [[wikipedia:isopregnanolone|isopregnanolone]] and [[wikipedia:epipregnanolone|epipregnanolone]].<ref name="Kolatorova Vitku Suchopar Hill 2022 p. 7989">{{cite journal | last=Kolatorova | first=Lucie | last2=Vitku | first2=Jana | last3=Suchopar | first3=Josef | last4=Hill | first4=Martin | last5=Parizek | first5=Antonin | title=Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine | journal=International Journal of Molecular Sciences | volume=23 | issue=14 | date=2022-07-20 | issn=1422-0067 | pmid=35887338 | doi=10.3390/ijms23147989 | doi-access=free | page=7989}}</ref> | ||
Allopregnanolone and Pregnanolone are documented to have [[antidepressant]], [[anxiolytic]], stress reducing, antiagressive, [[sedative]], sleep aiding, [[analgesic]], [[amnesic]], [[wikipedia:anesthetic|anesthetic]], [[anticonvulsant]] & [[wikipedia:neuroprotective|neuroprotective]] effects.<ref name="Diviccaro Cioffi Falvo Giatti 2022 p. ">{{cite journal | last=Diviccaro | first=Silvia | last2=Cioffi | first2=Lucia | last3=Falvo | first3=Eva | last4=Giatti | first4=Silvia | last5=Melcangi | first5=Roberto Cosimo | title=Allopregnanolone: An overview on its synthesis and effects | journal=Journal of Neuroendocrinology | volume=34 | issue=2 | date=2022 | issn=0953-8194 | pmid=34189791 | doi=10.1111/jne.12996 | page=}}</ref><ref name="PubChem p788">{{cite web | title=Brexanolone | website=PubChem | url=https://pubchem.ncbi.nlm.nih.gov/compound/92786 | access-date=2024-03-12}}</ref>Allopregnanolone and Pregnanolone act as positive allosteric modulators of [[GABA]]<sub>A</sub> whereas isopregnanolone and epipregnanolone selectively counteract GABA<sub>A</sub> as well as the sedative and anesthetic effects.<ref name="Kolatorova Vitku Suchopar Hill 2022 p. 7989">{{cite journal | last=Kolatorova | first=Lucie | last2=Vitku | first2=Jana | last3=Suchopar | first3=Josef | last4=Hill | first4=Martin | last5=Parizek | first5=Antonin | title=Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine | journal=International Journal of Molecular Sciences | volume=23 | issue=14 | date=2022-07-20 | issn=1422-0067 | pmid=35887338 | doi=10.3390/ijms23147989 | doi-access=free | page=7989}}</ref> | Allopregnanolone and Pregnanolone are documented to have [[antidepressant]], [[anxiolytic]], stress reducing, antiagressive, [[sedative]], sleep aiding, [[analgesic]], [[amnesic]], [[wikipedia:anesthetic|anesthetic]], [[anticonvulsant]] & [[wikipedia:neuroprotective|neuroprotective]] effects.<ref name="Diviccaro Cioffi Falvo Giatti 2022 p.">{{cite journal | last=Diviccaro | first=Silvia | last2=Cioffi | first2=Lucia | last3=Falvo | first3=Eva | last4=Giatti | first4=Silvia | last5=Melcangi | first5=Roberto Cosimo | title=Allopregnanolone: An overview on its synthesis and effects | journal=Journal of Neuroendocrinology | volume=34 | issue=2 | date=2022 | issn=0953-8194 | pmid=34189791 | doi=10.1111/jne.12996 | page=}}</ref><ref name="PubChem p788">{{cite web | title=Brexanolone | website=PubChem | url=https://pubchem.ncbi.nlm.nih.gov/compound/92786 | access-date=2024-03-12}}</ref>Allopregnanolone and Pregnanolone act as positive allosteric modulators of [[GABA]]<sub>A</sub> whereas isopregnanolone and epipregnanolone selectively counteract GABA<sub>A</sub> as well as the sedative and anesthetic effects.<ref name="Kolatorova Vitku Suchopar Hill 2022 p. 7989">{{cite journal | last=Kolatorova | first=Lucie | last2=Vitku | first2=Jana | last3=Suchopar | first3=Josef | last4=Hill | first4=Martin | last5=Parizek | first5=Antonin | title=Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine | journal=International Journal of Molecular Sciences | volume=23 | issue=14 | date=2022-07-20 | issn=1422-0067 | pmid=35887338 | doi=10.3390/ijms23147989 | doi-access=free | page=7989}}</ref> | ||
==Subjective effects== | ==Subjective effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
{{effects/base | {{effects/base | ||
Line 35: | Line 35: | ||
You may select physical effects to add below [[Subjective effect index#Physical effects|here]]. | You may select physical effects to add below [[Subjective effect index#Physical effects|here]]. | ||
*'''[[Effect:: | *'''[[Effect::Increased bodily temperature]]''' - at high concentration progesterone elevates body temperature for ~1°C | ||
*'''[[Effect::Sedation]]''' | *'''[[Effect::Sedation]]''' | ||
*'''[[Effect::Pain relief]]''' | *'''[[Effect::Pain relief]]''' | ||
Line 104: | Line 104: | ||
{{effects/aftereffects| | {{effects/aftereffects| | ||
*'''[[Effect::Increased | *'''[[Effect::Increased libido]]''' | ||
*'''[[Effect:: | *'''[[Effect::Sleepiness]]''' | ||
}} | }} | ||
}} | }} | ||
===Experience reports=== | ===Experience reports=== | ||
There are currently {{#ask:[[Category:Progesterone]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]]. | There are currently {{#ask:[[Category:Progesterone]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]]. | ||
Line 116: | Line 117: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
'''Warning:''' Progesterone is a naturally occuring sex hormone, changing its levels might induce gender dysphoria or premenstrual syndrome. | '''Warning:''' Progesterone is a naturally occuring sex hormone, changing its levels might induce gender dysphoria or premenstrual syndrome. | ||
Line 122: | Line 122: | ||
It is strongly recommended that one use [[harm reduction practices]] when using this substance. | It is strongly recommended that one use [[harm reduction practices]] when using this substance. | ||
===Lethal dosage=== | ===Lethal dosage=== | ||
The observed LD50 in mice was 100mg/kg via intravenous, 327mg/kg intraperitoneal and > 200mg/kg orally, anasthetic effects were observed at 16mg/kg intraperitoneal.<ref name="OEHA2004">{{cite web | publisher=Office of Environmental Health Hazard Assessment California Environmental Protection Agency | title=EVIDENCE ON THE DEVELOPMENTAL AND REPRODUCTIVE TOXICITY OF Progesterone | url=https://oehha.ca.gov/media/downloads/proposition-65/chemicals/progeshid5.pdf | access-date=2024-03-12}}</ref> | The observed LD50 in mice was 100mg/kg via intravenous, 327mg/kg intraperitoneal and > 200mg/kg orally, anasthetic effects were observed at 16mg/kg intraperitoneal.<ref name="OEHA2004">{{cite web | publisher=Office of Environmental Health Hazard Assessment California Environmental Protection Agency | title=EVIDENCE ON THE DEVELOPMENTAL AND REPRODUCTIVE TOXICITY OF Progesterone | url=https://oehha.ca.gov/media/downloads/proposition-65/chemicals/progeshid5.pdf | access-date=2024-03-12}}</ref> | ||
===Tolerance and addiction potential=== | ===Tolerance and addiction potential=== | ||
Dependence potential of Progesterone has been sparsely reported by transfeminine people. There is one case report of a women on post menopausal HRT that documents addiction.<ref name="React Weekly 1996 p. 9">{{cite journal | author=&Na; | title=Progesterone abuse Adverse effects: case report | journal=Reactions Weekly | volume=&NA; | issue=599 | date=1996 | issn=0114-9954 | doi=10.2165/00128415-199605990-00031 | page=9}}</ref> | Dependence potential of Progesterone has been sparsely reported by transfeminine people. There is one case report of a women on post menopausal HRT that documents addiction.<ref name="React Weekly 1996 p. 9">{{cite journal | author=&Na; | title=Progesterone abuse Adverse effects: case report | journal=Reactions Weekly | volume=&NA; | issue=599 | date=1996 | issn=0114-9954 | doi=10.2165/00128415-199605990-00031 | page=9}}</ref> | ||
Tolerance to the offects of Progesterone metabolites on GABA will build within a few years and return to baseline within a few months after cessation.{{Citation needed|date=March 2024|reason=from a pharma perspective this estimate makes sense, but hasn't been medically investigated}} | Tolerance to the offects of Progesterone metabolites on GABA will build within a few years and return to baseline within a few months after cessation.{{Citation needed|date=March 2024|reason=from a pharma perspective this estimate makes sense, but hasn't been medically investigated}} | ||
===Interactions=== | ===Interactions=== | ||
Combining oral progesterone with food leads to a two fold increase in absorptions. <ref name="Simon Robinson Andrews Hildebrand 1993 pp. 26–33">{{cite journal | last=Simon | first=James A. | last2=Robinson | first2=Denise E. | last3=Andrews | first3=Mason C. | last4=Hildebrand | first4=James R. | last5=Rocci | first5=Mario L. | last6=Blake | first6=Richard E. | last7=Hodgen | first7=Gary D. | title=The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone | journal=Fertility and Sterility | volume=60 | issue=1 | date=1993 | doi=10.1016/S0015-0282(16)56031-2 | pages=26–33}}</ref> Since oral progesterone is a oil soluable reports of increased effects when combined with fatty foods do seem plausible. | Combining oral progesterone with food leads to a two fold increase in absorptions. <ref name="Simon Robinson Andrews Hildebrand 1993 pp. 26–33">{{cite journal | last=Simon | first=James A. | last2=Robinson | first2=Denise E. | last3=Andrews | first3=Mason C. | last4=Hildebrand | first4=James R. | last5=Rocci | first5=Mario L. | last6=Blake | first6=Richard E. | last7=Hodgen | first7=Gary D. | title=The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone | journal=Fertility and Sterility | volume=60 | issue=1 | date=1993 | doi=10.1016/S0015-0282(16)56031-2 | pages=26–33}}</ref> Since oral progesterone is a oil soluable reports of increased effects when combined with fatty foods do seem plausible. | ||
Line 141: | Line 144: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Hormone]] | |||
*[[GABA]] | |||
*[[Estradiol]] | |||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Progesterone Progesterone(hormone) (Wikipedia)] | |||
*[https://en.wikipedia.org/wiki/Progesterone_(medication) Progesterone(medication) (Wikipedia)] | |||
*[https://go.drugbank.com/drugs/DB00396 Progesterone (DrugBank)] | |||
*[https://www.drugs.com/progesterone.html Progesterone (Drugs.com)] | |||
==References== | ==References== | ||
Line 158: | Line 162: | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Hormone]] | [[Category:Hormone]] | ||